Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Clin Pharmacol ; 30(1): 63-70, 1990 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2167717

RESUMO

1. The possible involvement of the benzodiazepine (BZD)-GABAA-receptor complex in mediating CNS stimulatory effects of fluoroquinolones was tested in vitro, in a binding inhibition assay and in vivo, in a clinical drug interaction study using electro-encephalogram (EEG) monitoring. 2. The specific binding of [3H]-flunitrazepam to rat synaptic brain membranes was inhibited by various fluoroquinolones in a concentration-dependent manner. 3. Ofloxacin had CNS-stimulating effects as revealed by the EEG which were slightly augmented by flumazenil but reversed by coadministration of midazolam. 4. In conclusion, our findings suggest that clinically observed CNS adverse effects of fluoroquinolones could be mediated at least in part through interaction with the BZD-GABAA-receptor complex and may be controlled by BZD agonist administration.


Assuntos
Quinolonas/farmacologia , Receptores de GABA-A/efeitos dos fármacos , Adulto , Animais , Química Encefálica , Ciprofloxacina/efeitos adversos , Ciprofloxacina/farmacologia , Método Duplo-Cego , Eletroencefalografia , Feminino , Flunitrazepam/farmacologia , Humanos , Técnicas In Vitro , Masculino , Pessoa de Meia-Idade , Norfloxacino/efeitos adversos , Norfloxacino/farmacologia , Ofloxacino/efeitos adversos , Ofloxacino/farmacologia , Quinolonas/efeitos adversos , Ensaio Radioligante , Distribuição Aleatória , Ratos , Ratos Endogâmicos , Membranas Sinápticas/efeitos dos fármacos , Membranas Sinápticas/metabolismo
3.
Biochem Pharmacol ; 38(15): 2473-8, 1989 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-2502983

RESUMO

Recent data suggest that desmethyldiazepam (DD), a major metabolite of several benzodiazepines (BZD), might be of natural origin. Therefore we tried to quantify DD and diazepam (D) in animals during maturation (e.g. hen, chicken, eggs), in brain of species at different evolutionary stages e.g. salmon, frog, monitor/reptile, rat, cat, dog, deer, bovine) including newborn and adult humans. Since low concentrations of DD (range 0.01-0.04 ng/g wet wt) and D (range 0.005-0.02 ng/g) could be measured in different species by sensitive and specific mass spectrometry (GC-MS), we analysed also several plants (e.g. maize corn, lentils, potatoes, soybeans, rice, mushrooms). Again, DD and D could be detected in low amounts (0.005-0.05 ng/g) in some plant products. This would suggest that DD and D might be of natural origin and incorporated via the foodchain into the animal and human body. The biological role or clinical relevance of these intriguing findings need still to be elucidated.


Assuntos
Química Encefálica , Diazepam/análogos & derivados , Diazepam/isolamento & purificação , Nordazepam/isolamento & purificação , Plantas/análise , Animais , Benzodiazepinas/isolamento & purificação , Cromatografia Líquida de Alta Pressão , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Ensaio Radioligante , Especificidade da Espécie
4.
Pharm Res ; 6(1): 1-3, 1989 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2497443

RESUMO

Three research groups have provided evidence that benzodiazepines might be also of natural origin. In the brain of different species including humans and in several plant products, desmethyldiazepam and diazepam are detectable by immunological methods and gas chromatography--mass spectrometry. Thus, benzodiazepines represent natural drugs which may be incorporated into animals and humans through plant products. Whether the measured low concentrations (ranging from 0.01 up to 600 ng/g wet weight) have any biological role or clinical significance remains to be determined.


Assuntos
Benzodiazepinas/fisiologia , Animais , Benzodiazepinas/análise , Diazepam/análise , Diazepam/fisiologia , Nordazepam/análise , Nordazepam/fisiologia
6.
J Chromatogr ; 420(2): 349-56, 1987 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-3693506

RESUMO

A rapid and sensitive analytical procedure is described for the simultaneous measurement of tolmetin (T), tolmetin glucuronide (1 beta-TG) and the isomers of tolmetin glucuronide in plasma and urine. A reversed-phase liquid chromatographic system is used with an ion-pairing mobile phase of methanol-tetrabutylammonium hydrogensulfate buffered to pH 4.5 and kept at a constant temperature of 50 degrees C. Detection is by UV at 313 nm. Plasma (0.5 ml) and urine (0.1 ml) are collected in pre-cooled containers and immediately adjusted to pH 3.0 to minimize TG isomerization and hydrolysis. Samples are then deproteinated with acetonitrile, the supernatant is evaporated to dryness and reconstituted in an acetate buffer (pH 4.5), and 50 microliters are injected onto the system. Using zomepirac as the internal standard, the measurable, linear concentration ranges are 0.05-50 micrograms/ml for T in plasma and 0.025-50 micrograms/ml for T in urine. Chromatographic peaks representing T,1 beta-TG and three isomers of TG were identified, all with retention times less than 10 min. The need for special handling of biological samples is discussed.


Assuntos
Pirróis/análise , Tolmetino/análise , Cromatografia Líquida de Alta Pressão , Estabilidade de Medicamentos , Glucuronatos/análise , Glucuronatos/sangue , Glucuronatos/urina , Humanos , Indicadores e Reagentes , Isomerismo , Espectrofotometria Ultravioleta , Tolmetino/sangue , Tolmetino/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...